Finance

Beta
Lists
SIGHT:EPA
Gensight Biologics SA
€0.084
-2.11%
(-0.0018) 1D
Jun 5, 5:35:14 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SIGHT...
Open
€0.09
High
€0.09
Low
€0.08
Mkt. cap
18.69M
Avg. vol.
708.23K
Volume
324.37K
52-wk high
€0.25
52-wk low
€0.08
EPS
-€0.08
Shares outstanding
235.04M
No. of employees
13
Open
€0.09
High
€0.09
Low
€0.08
Mkt. cap
18.69M
Avg. vol.
708.23K
Volume
324.37K
52-wk high
€0.25
52-wk low
€0.08
EPS
-€0.08
Shares outstanding
235.04M
No. of employees
13
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to SIGHT in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for SIGHT in the last 3 months.
Highest
Current €0.08
€0.40 (+377.90%)
Average
€0.40 (+377.90%)
Lowest
€0.40 (+377.90%)
News stories
From sources across the web
About Gensight Biologics SA
CEO-
Employees13
Founded2012
HeadquartersParis, Île-de-France, France
SectorBiotechnology
Websitegensight-biologics.com
Last report
Jan 8, 2026
Fiscal period
Q4 2025
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
302.00K / -
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
24.00K
24.00K
302.00K
302.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.14M
2.14M
1.08M
1.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.28M
1.28M
1.36M
1.36M
Operating expense
3.42M
3.42M
2.43M
2.43M
Total operating expenses
3.42M
3.42M
2.43M
2.43M
Operating income
-3.40M
-3.40M
-2.13M
-2.13M
Other non operating income
697.00K
697.00K
436.00K
436.00K
EBT including unusual items
-3.49M
-3.49M
-2.53M
-2.53M
EBT excluding unusual items
-3.49M
-3.49M
-2.53M
-2.53M
Income tax expense
-4.50K
-4.50K
2.00K
2.00K
Effective tax rate
0.13%
0.13%
-0.08%
-0.08%
Other operating expenses
-
-
-
-
Net income
-3.48M
-3.48M
-2.53M
-2.53M
Net profit margin
-14,514.58%
-14,514.58%
-839.24%
-839.24%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-660.00K
-660.00K
-784.50K
-784.50K
Net interest expenses
-660.00K
-660.00K
-784.50K
-784.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.36M
-3.36M
-2.09M
-2.09M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer